Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Richard Breen

Pediatrics Hilliard, OH Medical Doctor

NPI 1689667214 CMS profile 348253

3643 Ridge Mill Dr, Hilliard, OH 43026

Open in the dashboard

General payments

$42,839

557 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Richard Breen of Hilliard, OH is reported in the CMS Open Payments database as having received $42,839 across 557 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $30,565 113
2024 General $1,387 81
2023 General $6,975 88
2022 General $1,438 86
2021 General $1,235 101
2020 General $582 42
2019 General $658 46

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Richard Breen
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Richard Breen were reported at $30,565. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Richard Breen Pediatrics median Middle half National median
2019 $658 $86 $31–$183 $163
2020 $582 $49 $22–$110 $114
2021 $1,235 $68 $27–$158 $132
2022 $1,438 $77 $30–$173 $149
2023 $6,975 $88 $33–$190 $160
2024 $1,387 $94 $34–$206 $164
2025 $30,565 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Supernus Pharmaceuticals, Inc. $36,874 178 payments
  2. Tris Pharma Inc $966 92 payments
  3. Corium, Inc. $932 45 payments
  4. Neos Therapeutics, LP $550 46 payments
  5. Ironshore Pharmaceuticals Inc. $409 22 payments
  6. Merck Sharp & Dohme Corporation $382 21 payments
  7. Pfizer Inc. $324 18 payments
  8. Takeda Pharmaceuticals U.S.A., Inc. $322 20 payments
  9. Sanofi Pasteur Inc. $229 15 payments
  10. Cranial Technologies, Inc $214 13 payments
  11. Other $1,638 87 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Honoraria $25,675 12 payments
  2. Food and Beverage $8,749 520 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,275 1 payment
  4. Travel and Lodging $4,128 22 payments
  5. Education $12 2 payments
Products named General payments · program years 2019–2025
  1. Qelbree Viloxazine Hydrochloride $30,443 117 payments
  2. QELBREE Psychology $6,431 61 payments
  3. Azstarys $932 45 payments
  4. Dyanavel XR Adhd $434 49 payments
  5. Dyanavel XR Adhd $417 34 payments
  6. GARDASIL 9 $370 20 payments
  7. COTEMPLA XR-ODT $365 31 payments
  8. VYVANSE $348 19 payments
  9. VAXELIS $318 17 payments
  10. JORNAY PM $314 17 payments
  11. Other $4,600 271 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

557 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record